Literature DB >> 12517852

Extended virulence genotype of pathogenic Escherichia coli isolates carrying the afa-8 operon: evidence of similarities between isolates from humans and animals with extraintestinal infections.

Jean Pierre Girardeau1, Lila Lalioui, A Mohamed Ou Said, Christophe De Champs, Chantal Le Bouguénec.   

Abstract

The afimbrial AfaE-VIII adhesin is common among Escherichia coli isolates from calves with intestinal and/or extraintestinal infections and from humans with sepsis or pyelonephritis. The virulence genotypes of 77 Escherichia coli afa-8 isolates from farm animals and humans were compared to determine whether any trait of commonality exists between isolates of the different host species. Over half of the extraintestinal afa-8 isolates were associated with pap and f17Ac adhesin genes and contained virulence genes (pap, hly, and cnf1) which are characteristic of human extraintestinal pathogenic E. coli (ExPEC). PapG, which occurs as three known variants (variants I to III), is encoded by the corresponding three alleles of papG. Among the pap-positive strains, new papG variants (papGrs) that differed from the isolates with genes for the three adhesin classes predominated over isolates with papG allele III, which in turn were more prevalent than those with allele II. The data showed the substantial prevalence of the enteroaggregative E. coli heat-stable enterotoxin gene (east1) among afa-8 isolates. Most of the afa-8 isolates harbored the high-pathogenicity island (HPI) present in pathogenic Yersinia; however, two-thirds of the HPI-positive strains shared a truncated HPI integrase gene. The presence of ExPEC-associated virulence factors (VFs) in extraintestinal isolates that carry genes typical of enteric strains and that express O antigens associated with intestinal E. coli is consistent with transfer of VFs and O-antigen determinants between ExPEC and enteric strains. The similarities between animal and human ExPEC strains support the hypothesis of overlapping populations, with members of certain clones or clonal groups including animal and human strains. The presence of multiple-antibiotic-resistant bovine afa-8 strains among such clones may represent a potential public health risk.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517852      PMCID: PMC149575          DOI: 10.1128/JCM.41.1.218-226.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  53 in total

1.  Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC.

Authors:  T A Russo; J R Johnson
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

2.  An Escherichia coli reference collection group B2- and uropathogen-associated polymorphism in the rpoS-mutS region of the E. coli chromosome.

Authors:  D E Culham; J M Wood
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

3.  afa-8 Gene cluster is carried by a pathogenicity island inserted into the tRNA(Phe) of human and bovine pathogenic Escherichia coli isolates.

Authors:  L Lalioui; C Le Bouguénec
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Phylogenetic and pathotypic similarities between Escherichia coli isolates from urinary tract infections in dogs and extraintestinal infections in humans.

Authors:  J R Johnson; A L Stell; P Delavari; A C Murray; M Kuskowski; W Gaastra
Journal:  J Infect Dis       Date:  2001-02-21       Impact factor: 5.226

5.  Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli.

Authors:  J R Johnson; P Delavari; M Kuskowski; A L Stell
Journal:  J Infect Dis       Date:  2000-11-22       Impact factor: 5.226

6.  Molecular comparison of extraintestinal Escherichia coli isolates of the same electrophoretic lineages from humans and domestic animals.

Authors:  J R Johnson; P Delavari; A L Stell; T S Whittam; U Carlino; T A Russo
Journal:  J Infect Dis       Date:  2000-11-28       Impact factor: 5.226

7.  The Yersinia high-pathogenicity island is highly predominant in virulence-associated phylogenetic groups of Escherichia coli.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  FEMS Microbiol Lett       Date:  2001-03-15       Impact factor: 2.742

8.  Gene conservation and loss in the mutS-rpoS genomic region of pathogenic Escherichia coli.

Authors:  C J Herbelin; S C Chirillo; K A Melnick; T S Whittam
Journal:  J Bacteriol       Date:  2000-10       Impact factor: 3.490

9.  Prevalence of virulence genes and clonality in Escherichia coli strains that cause bacteremia in cancer patients.

Authors:  F Hilali; R Ruimy; P Saulnier; C Barnabé; C Lebouguénec; M Tibayrenc; A Andremont
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

10.  Canine feces as a reservoir of extraintestinal pathogenic Escherichia coli.

Authors:  J R Johnson; A L Stell; P Delavari
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

View more
  18 in total

1.  Association of virulence genotype with phylogenetic background in comparison to different seropathotypes of Shiga toxin-producing Escherichia coli isolates.

Authors:  Jean Pierre Girardeau; Alessandra Dalmasso; Yolande Bertin; Christian Ducrot; Séverine Bord; Valérie Livrelli; Christine Vernozy-Rozand; Christine Martin
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

2.  Associations between multidrug resistance, plasmid content, and virulence potential among extraintestinal pathogenic and commensal Escherichia coli from humans and poultry.

Authors:  Timothy J Johnson; Catherine M Logue; James R Johnson; Michael A Kuskowski; Julie S Sherwood; H John Barnes; Chitrita DebRoy; Yvonne M Wannemuehler; Mana Obata-Yasuoka; Lodewijk Spanjaard; Lisa K Nolan
Journal:  Foodborne Pathog Dis       Date:  2011-10-11       Impact factor: 3.171

Review 3.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Role of the vpe carbohydrate permease in Escherichia coli urovirulence and fitness in vivo.

Authors:  Vanessa Martinez-Jéhanne; Christophe Pichon; Laurence du Merle; Olivier Poupel; Nadège Cayet; Christiane Bouchier; Chantal Le Bouguénec
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

Review 5.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  Serotypes, virulence factors, and antimicrobial susceptibilities of vaginal and fecal isolates of Escherichia coli from giant pandas.

Authors:  Xin Wang; Qigui Yan; Xiaodong Xia; Yanming Zhang; Desheng Li; Chengdong Wang; Shijie Chen; Rong Hou
Journal:  Appl Environ Microbiol       Date:  2013-06-21       Impact factor: 4.792

7.  Human diffusely adhering Escherichia coli expressing Afa/Dr adhesins that use human CD55 (decay-accelerating factor) as a receptor does not bind the rodent and pig analogues of CD55.

Authors:  Sylvie Hudault; O Brad Spiller; B Paul Morgan; Alain L Servin
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  Host species-specific translocation of Escherichia coli.

Authors:  M Katouli; N L Ramos; C G Nettelbladt; M Ljungdahl; W Robinson; H M Ison; A Brauner; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-13       Impact factor: 3.267

9.  Characteristics and virulence genes of Escherichia coli isolated from septicemic calves in southeast of Iran.

Authors:  Reza Ghanbarpour; Eric Oswald
Journal:  Trop Anim Health Prod       Date:  2008-12-10       Impact factor: 1.559

10.  Role of deoxyribose catabolism in colonization of the murine intestine by pathogenic Escherichia coli strains.

Authors:  Vanessa Martinez-Jéhanne; Laurence du Merle; Christine Bernier-Fébreau; Codruta Usein; Amy Gassama-Sow; Abdul-Aziz Wane; Malika Gouali; Maria Damian; Awa Aïdara-Kane; Yves Germani; Arnaud Fontanet; Bernadette Coddeville; Yann Guérardel; Chantal Le Bouguénec
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.